Showing results (21-30 of 67) with videos related to
Sort By:
Pageof 7
Pharmacology|January 1, 1975
Reversal of the 6-hydroxydopamine-induced suppression of a CAR by drugs facilitating central catecholaminergic mechanismsM Ruiz, J M MontiPharmacology, Biochemistry, and Behavior|September 1, 1975
Increased disrupting effects of haloperidol on a conditioned avoidance response after 6-hydroxydopamine treatmentJ M Monti, M RuizLife Sciences|May 24, 2000
Role of dorsal raphe nucleus serotonin 5-HT1A receptor in the regulation of REM sleepJ M Monti, D MontiNeuropharmacology|May 1, 1994
Stereoselective antagonism by the pindolol enantiomers of 8-OH-DPAT-induced changes of sleep and wakefulnessJ M Monti, H JantosPharmacology, Biochemistry, and Behavior|November 1, 1975
Spontaneous behavior and sleep-wakefulness cycle in isolated and paired REM sleep deprived-marihuana treated ratsJ M Monti, E A CarliniBiological Signals and Receptors|October 12, 2000
A critical assessment of the melatonin effect on sleep in humansJ M Monti, D P CardinaliEuropean Journal of Pharmacology|November 16, 1993
The effects of selective activation of the 5-HT3 receptor with m-chlorophenylbiguanide on sleep and wakefulness in the ratA Ponzoni, J M Monti, H JantosSleep|January 6, 2001
Conventional and power spectrum analysis of the effects of zolpidem on sleep EEG in patients with chronic primary insomniaJ M Monti, F Alvariño, D MontiBehavioural Brain Research|May 30, 2001
Increase of waking and reduction of NREM and REM sleep after nitric oxide synthase inhibition: prevention with GABA(A) or adenosine A(1) receptor agonistsJ M Monti, H Jantos, D MontiNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 1, 1990
Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in ratsJ M Monti, M Fernández, H JantosPageof 7